Eisai
4523.T
#1880
Rank
C$12.42 B
Marketcap
$44.08
Share price
0.82%
Change (1 day)
-36.42%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.07. In 2022 the company made an earnings per share (EPS) of $2.25 a decrease over its 2021 EPS that were of $9.99.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9530.97%
2022$2.25-77.48%
2021$9.99-41.88%
2020$17.19-0.94%
2019$17.3652.59%
2018$11.38124.17%
2017$5.07-49.42%
2016$10.0337.08%
2015$7.32-11.75%
2014$8.29-3.23%
2013$8.57-18.56%
2012$10.52-15.51%
2011$12.46-3.75%
2010$12.94-1.36%
2009$13.12